experimental group:Improved CAR-T cell
Sponsors
Tianjin First Central Hospital
Conditions
B-cell lymphomaCD19-positive hematological malignancies
Early Phase 1
Single-center, single-arm, non-blind safety and effectiveness clinical study of improved CAR-T cell therapy for B-cell lymphoma
RecruitingChiCTR2000041049
Start: 2020-12-31Updated: 2021-11-02
Single-Center, single-arm, non-blind safety and effectiveness clinical study of improved CAR-T cell therapy for B-cell lymphoma
RecruitingChiCTR2100052677
Start: 2021-11-01Updated: 2022-08-08